CTRI/2021/09/036990尚未招募未知
Immersive virtual reality to reduce neuropathic pain in persons with Spinal cord injury: A double blind Randomized controlled trial - VR-NEUPASCI
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Persons with SCI between 16 and 60 years of age, both genders and who are able to follow therapy instructions and capable of participating in daily therapy sessions.
- •Persons with SCI thoracic level lesion with Complete (ASIA â?? A) and sensory incomplete (ASIA - B) and motor incomplete (ASIA - C) lesions based on â??The International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI)â??
- •Presence of neuropathic pain with LANSS score of 12 or more
- •Persons with ongoing stable pharmacological treatment for at least 2 weeks prior to the study and throughout the trial
排除标准
- •SCI persons with associated traumatic brain injury and comorbidities such as neurological and psychiatric disorders, visual impairment and who are not willing to give consent to participate in the study will be excluded.
研究者
相似试验
已完成
不适用
Virtual Reality Walking for Neuropathic Pain in Spinal Cord InjurySpinal Cord InjuriesNeuropathic PainNCT03735017University of Alabama at Birmingham27
已完成
不适用
Immersive Virtual Reality for Chronic Neuropathic Pain After Spinal Cord Injury: A Feasibility TrialSpinal Cord InjuriesNeuralgiaChronic PainNCT04700033Icahn School of Medicine at Mount Sinai23
Unknown
3 期
Virtual Reality for Chronic Neuropathic PainSpinal Cord InjuriesNeuropathic PainNCT03592394Kathleen Friel40
尚未招募
不适用
Virtual reality immersion therapy for symptom management in Palliative Care inpatients: feasibility trial.Terminal illnessPainDyspnoeaNauseaMental Health - AnxietyAnaesthesiology - Pain managementMental Health - DepressionPublic Health - Health service researchAnxietyDepressionACTRN12622001368729Visor Immersive70
已完成
不适用
Virtual Reality (VR) to Improve Quality of Life in Patients Diagnosed With Neurological DisordersChronic PainNeurological DisorderMultiple SclerosisNCT03606668NYU Langone Health20